Skip to content

Ultrasonographic Fetal Soft Markers and Aneuploidy

Correlation Between Ultrasonographic Fetal Soft Markers and Aneuploidy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03861520
Enrollment
100
Registered
2019-03-04
Start date
2019-03-14
Completion date
2020-04-05
Last updated
2020-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft Markers

Keywords

Anomaly scan, Anuploidy

Brief summary

The purpose of this study is to investigate the prevalence of soft markers which will be identified during a second trimester ultrasound. Secondary aims were to estimate the association between the soft markers and trisomies 13, 18 and 21 as well as the effect on the number of invasive tests will be performed.

Interventions

DEVICEMidtrimester anomaly scan

A detailed anomaly scan to detect soft markers at 16 to 24 weeks pregnancy

GENETICFetal Karyotyping

Fetal karyotyping after birth to confirm chromosomal anomaly diagnosed clinically

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. pregnant woman between (16-24) weeks of gestation. 2. singelton pregnancy.

Exclusion criteria

1. Multiple pregnancies. 2. Mental condition rendering the patients unable to understand the nature and scope of the study.

Design outcomes

Primary

MeasureTime frameDescription
To study the association between soft markers identified at second trimester ultrasound and aneuploidy.1 yearfetal soft markers detection which include the following: * choroid plexus cyst. * Mild ventriculomegaly. * Enlarged cistern magna. * Nasal bone hypoplasia. * Increased nuchal fold. * Echogenic cardiac focus. * Single umbilical artery. * Pyelectasis. * Echogenic bowl. * Short femur. * Short humerus. All data will be collected and statistics will be done for the correlation between one or more soft markers with structural anomalies and its relation with aneuploidy.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026